Selective killing of IL6 receptor bearing myeloma cells using recombinant IL6-Pseudomonas toxin.
Siegall
C B
CB
Division of Cancer Biology and Diagnosis and Centers, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892.
FitzGerald
D J
DJ
Pastan
I
I
D036002:ADP Ribose Transferases; D000818:Animals; D001427:Bacterial Toxins / Q000494:pharmacology*; D005098:Exotoxins / Q000494:pharmacology*; D006801:Humans; D015850:Interleukin-6 / Q000378:metabolism / Q000494:pharmacology*; D051379:Mice; D009101:Multiple Myeloma / Q000473:pathology*; D011550:Pseudomonas aeruginosa; D011971:Receptors, Immunologic / Q000032:analysis*; D019947:Receptors, Interleukin-6; D011993:Recombinant Fusion Proteins / Q000494:pharmacology*; D014407:Tumor Cells, Cultured / Q000187:drug effects; D037521:Virulence Factors; D000097668:Pseudomonas aeruginosa Exotoxin A
D036002:ADP Ribose Transferases; D001427:Bacterial Toxins; D005098:Exotoxins; D015850:Interleukin-6; D011971:Receptors, Immunologic; D019947:Receptors, Interleukin-6; D011993:Recombinant Fusion Proteins; D037521:Virulence Factors; D000097668:Pseudomonas aeruginosa Exotoxin A